Page last updated: 2024-09-04

2-deoxy-2-fluorogalactose and Cancer of Liver

2-deoxy-2-fluorogalactose has been researched along with Cancer of Liver in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bak-Fredslund, K; Fode, MM; Høyer, M; Petersen, JB; Sørensen, M; Worm, E1
Bak-Fredslund, KP; Keiding, S; Munk, OL; Sørensen, M1
Bender, D; Frisch, K; Keiding, S; Sørensen, M1
Fujiwara, T; Fukuda, H; Goto, R; Ido, T; Itoh, M; Iwata, R; Murata, K; Tada, M; Takahashi, J; Yoshioka, S1
Amthauer, H; Felix, R; Grueters, A; Hosten, N; Kreissig, R; Krude, H; Steinmueller, P; Stroszczynski, C1
Fukuda, H1

Trials

1 trial(s) available for 2-deoxy-2-fluorogalactose and Cancer of Liver

ArticleYear
A phase I study on stereotactic body radiotherapy of liver metastases based on functional treatment planning using positron emission tomography with 2-[
    Acta oncologica (Stockholm, Sweden), 2017, Volume: 56, Issue:11

    Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Follow-Up Studies; Fucose; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiosurgery; Radiotherapy Planning, Computer-Assisted

2017

Other Studies

5 other study(ies) available for 2-deoxy-2-fluorogalactose and Cancer of Liver

ArticleYear
2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT of hepatocellular carcinoma is not improved by co-administration of galactose.
    Nuclear medicine and biology, 2016, Volume: 43, Issue:9

    Topics: Aged; Carcinoma, Hepatocellular; Fucose; Galactose; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography

2016
The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma.
    European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Hepatocellular; Feasibility Studies; Female; Fucose; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radioactive Tracers; Retrospective Studies; Tomography, X-Ray Computed

2011
[A case of hepatocellular carcinoma with lumbar bone metastasis with high uptake of 18F-fluorodeoxygalactose in PET].
    Kaku igaku. The Japanese journal of nuclear medicine, 1994, Volume: 31, Issue:11

    Topics: Carcinoma, Hepatocellular; Female; Fluorine Radioisotopes; Fucose; Humans; Liver Neoplasms; Lumbar Vertebrae; Middle Aged; Spinal Neoplasms; Tomography, Emission-Computed

1994
The use of FDG-PET and CT for the staging of adrenocortical carcinoma in children.
    Pediatric radiology, 2000, Volume: 30, Issue:5

    Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Diagnosis, Differential; Fucose; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Staging; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed

2000
[Diagnosis of liver tumors with 18F-FDG and 18F-FDGal using PET].
    Nihon rinsho. Japanese journal of clinical medicine, 1991, Volume: 49, Issue:8

    Topics: Carcinoma, Hepatocellular; Deoxyglucose; Fluorodeoxyglucose F18; Fucose; Humans; Liver Neoplasms; Tomography, Emission-Computed

1991